Immunity clinical trials

Explore recruiting immunity clinical trials.

Recruiting immunity studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Immunity trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Measles-mumps-rubella vaccine (MMR) at 6 months of age: Long-term follow-up

Denmark

Therapeutic use (Phase IV) EU CTIS Study details

Avian and seasonal influenza vaccine induced immune responses

Finland

Therapeutic use (Phase IV) EU CTIS Study details

A single-center, randomized, single-blind, phase 4 study to evaluate the enhancement of mucosal immunity in infants through maternal vaccination during breastfeeding (MEALAC-01).

Belgium

Therapeutic use (Phase IV) EU CTIS Study details

(Pre-BCGvacc) BCG vaccination: can pre-vaccination immune status predict outcome?

Netherlands

Phase III and phase IV (Integrated) EU CTIS Study details

A clinical phase IV trial to examine cellular and humoral immunity against measles and chickenpox in children and adolescents 0-18 years in childhood cancer.

Sweden

Therapeutic use (Phase IV) EU CTIS Study details

Late immunity following single immunization with GA2 sporozoites (GACHA)

Netherlands

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Immunity trials by city

Immunity in Toronto Immunity in Vancouver Immunity in Montreal Immunity in Calgary Immunity in Edmonton Immunity in Ottawa Immunity in Winnipeg Immunity in Quebec City Immunity in Hamilton Immunity in Kitchener Immunity in London Immunity in Halifax Immunity in New York Immunity in Los Angeles Immunity in Chicago Immunity in Houston

Immunity clinical trials

Recruiting immunity studies right now

Investigating Gender and Sex Differences in Immune Responses Through Vaccination of Transgender and Cisgender Persons

Human Immune Response to Ixodes Scapularis Tick Bites

Evaluating the Dose, Safety, Tolerability, and Immunogenicity of Mosaic Hexavalent Influenza Vaccine VRCFLUMOS0116-00-VP (FluMos-v2) With and Without ALFQ Adjuvant in Healthy Adults

EXERCISE AND THE IMMUNE RESPONSE IN LUNG CANCER

A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine and a Marketed Measles, Mumps and Rubella Vaccine When Administered as Intramuscular Injection to Healthy Children 12 to 15 Months of Age

Viral Specific T-Lymphocytes to Treat Infection With Adenovirus, Cytomegalovirus or Epstein-Barr Virus in Patients With Compromised Immunity

A Pilot Study to Evaluate the Systemic Effect of Oral Supplementation With AM3 in Patients With Metabolic Syndrome.

PTCy and and Ruxolitinib for GVHD Prophylaxis After HSCT With Thymoglobulin in Conditioning Regimen in Patients With Inborn Errors of Immunity

A Study on the Safety and Immune Response of Investigational mRNA Seasonal Flu/COVID-19 Combination Vaccine in Adults

Modulating Immune Responses After Consistent Lipid Exposure

Psoriatic Immune Response to Tildrakizumab

Description of the Immune Response to Yellow Fever Vaccination

Also recruiting in Europe

Measles-mumps-rubella vaccine (MMR) at 6 months of age: Long-term follow-up

Avian and seasonal influenza vaccine induced immune responses

A single-center, randomized, single-blind, phase 4 study to evaluate the enhancement of mucosal immunity in infants through maternal vaccination during breastfeeding (MEALAC-01).

(Pre-BCGvacc) BCG vaccination: can pre-vaccination immune status predict outcome?

A clinical phase IV trial to examine cellular and humoral immunity against measles and chickenpox in children and adolescents 0-18 years in childhood cancer.

Late immunity following single immunization with GA2 sporozoites (GACHA)

Immunity trials by city

Other conditions